173 related articles for article (PubMed ID: 15087285)
1. Acute activation and phosphorylation of endothelial nitric oxide synthase by HMG-CoA reductase inhibitors.
Harris MB; Blackstone MA; Sood SG; Li C; Goolsby JM; Venema VJ; Kemp BE; Venema RC
Am J Physiol Heart Circ Physiol; 2004 Aug; 287(2):H560-6. PubMed ID: 15087285
[TBL] [Abstract][Full Text] [Related]
2. Reciprocal phosphorylation and regulation of endothelial nitric-oxide synthase in response to bradykinin stimulation.
Harris MB; Ju H; Venema VJ; Liang H; Zou R; Michell BJ; Chen ZP; Kemp BE; Venema RC
J Biol Chem; 2001 May; 276(19):16587-91. PubMed ID: 11340086
[TBL] [Abstract][Full Text] [Related]
3. Acute activation of eNOS by statins involves scavenger receptor-B1, G protein subunit Gi, phospholipase C and calcium influx.
Datar R; Kaesemeyer WH; Chandra S; Fulton DJ; Caldwell RW
Br J Pharmacol; 2010 Aug; 160(7):1765-72. PubMed ID: 20649578
[TBL] [Abstract][Full Text] [Related]
4. Hydrogen peroxide activates endothelial nitric-oxide synthase through coordinated phosphorylation and dephosphorylation via a phosphoinositide 3-kinase-dependent signaling pathway.
Thomas SR; Chen K; Keaney JF
J Biol Chem; 2002 Feb; 277(8):6017-24. PubMed ID: 11744698
[TBL] [Abstract][Full Text] [Related]
5. A HMG-CoA reductase inhibitor possesses a potent anti-atherosclerotic effect other than serum lipid lowering effects--the relevance of endothelial nitric oxide synthase and superoxide anion scavenging action.
Sumi D; Hayashi T; Thakur NK; Jayachandran M; Asai Y; Kano H; Matsui H; Iguchi A
Atherosclerosis; 2001 Apr; 155(2):347-57. PubMed ID: 11254905
[TBL] [Abstract][Full Text] [Related]
6. Hsp90 and caveolin are key targets for the proangiogenic nitric oxide-mediated effects of statins.
Brouet A; Sonveaux P; Dessy C; Moniotte S; Balligand JL; Feron O
Circ Res; 2001 Nov; 89(10):866-73. PubMed ID: 11701613
[TBL] [Abstract][Full Text] [Related]
7. CCN1 acutely increases nitric oxide production via integrin αvβ3-Akt-S6K-phosphorylation of endothelial nitric oxide synthase at the serine 1177 signaling axis.
Hwang S; Lee HJ; Kim G; Won KJ; Park YS; Jo I
Free Radic Biol Med; 2015 Dec; 89():229-40. PubMed ID: 26393424
[TBL] [Abstract][Full Text] [Related]
8. A constituent of green tea, epigallocatechin-3-gallate, activates endothelial nitric oxide synthase by a phosphatidylinositol-3-OH-kinase-, cAMP-dependent protein kinase-, and Akt-dependent pathway and leads to endothelial-dependent vasorelaxation.
Lorenz M; Wessler S; Follmann E; Michaelis W; Düsterhöft T; Baumann G; Stangl K; Stangl V
J Biol Chem; 2004 Feb; 279(7):6190-5. PubMed ID: 14645258
[TBL] [Abstract][Full Text] [Related]
9. Nitric oxide production and regulation of endothelial nitric-oxide synthase phosphorylation by prolonged treatment with troglitazone: evidence for involvement of peroxisome proliferator-activated receptor (PPAR) gamma-dependent and PPARgamma-independent signaling pathways.
Cho DH; Choi YJ; Jo SA; Jo I
J Biol Chem; 2004 Jan; 279(4):2499-506. PubMed ID: 14593122
[TBL] [Abstract][Full Text] [Related]
10. Cyclosporin A inhibits flow-mediated activation of endothelial nitric-oxide synthase by altering cholesterol content in caveolae.
Lungu AO; Jin ZG; Yamawaki H; Tanimoto T; Wong C; Berk BC
J Biol Chem; 2004 Nov; 279(47):48794-800. PubMed ID: 15383526
[TBL] [Abstract][Full Text] [Related]
11. Shear stress stimulates phosphorylation of eNOS at Ser(635) by a protein kinase A-dependent mechanism.
Boo YC; Hwang J; Sykes M; Michell BJ; Kemp BE; Lum H; Jo H
Am J Physiol Heart Circ Physiol; 2002 Nov; 283(5):H1819-28. PubMed ID: 12384459
[TBL] [Abstract][Full Text] [Related]
12. Pitavastatin at low dose activates endothelial nitric oxide synthase through PI3K-AKT pathway in endothelial cells.
Wang J; Tokoro T; Matsui K; Higa S; Kitajima I
Life Sci; 2005 Mar; 76(19):2257-68. PubMed ID: 15733940
[TBL] [Abstract][Full Text] [Related]
13. Shear stress stimulates phosphorylation of endothelial nitric-oxide synthase at Ser1179 by Akt-independent mechanisms: role of protein kinase A.
Boo YC; Sorescu G; Boyd N; Shiojima I; Walsh K; Du J; Jo H
J Biol Chem; 2002 Feb; 277(5):3388-96. PubMed ID: 11729190
[TBL] [Abstract][Full Text] [Related]
14. HMG-CoA reductase inhibitor improves endothelial dysfunction in spontaneous hypertensive rats via down-regulation of caveolin-1 and activation of endothelial nitric oxide synthase.
Suh JW; Choi DJ; Chang HJ; Cho YS; Youn TJ; Chae IH; Kim KI; Kim CH; Kim HS; Oh BH; Park YB
J Korean Med Sci; 2010 Jan; 25(1):16-23. PubMed ID: 20052342
[TBL] [Abstract][Full Text] [Related]
15. Genistein acutely stimulates nitric oxide synthesis in vascular endothelial cells by a cyclic adenosine 5'-monophosphate-dependent mechanism.
Liu D; Homan LL; Dillon JS
Endocrinology; 2004 Dec; 145(12):5532-9. PubMed ID: 15319357
[TBL] [Abstract][Full Text] [Related]
16. Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase.
Endres M; Laufs U; Huang Z; Nakamura T; Huang P; Moskowitz MA; Liao JK
Proc Natl Acad Sci U S A; 1998 Jul; 95(15):8880-5. PubMed ID: 9671773
[TBL] [Abstract][Full Text] [Related]
17. Activation of endothelial nitric-oxide synthase by the p38 MAPK in response to black tea polyphenols.
Anter E; Thomas SR; Schulz E; Shapira OM; Vita JA; Keaney JF
J Biol Chem; 2004 Nov; 279(45):46637-43. PubMed ID: 15333638
[TBL] [Abstract][Full Text] [Related]
18. Hydroxy-methylglutaryl-coenzyme A reductase inhibition promotes endothelial nitric oxide synthase activation through a decrease in caveolin abundance.
Feron O; Dessy C; Desager JP; Balligand JL
Circulation; 2001 Jan; 103(1):113-8. PubMed ID: 11136695
[TBL] [Abstract][Full Text] [Related]
19. Aortic superoxide production at the early hyperglycemic stage in a rat type 2 diabetes model and the effects of pravastatin.
Kikuchi C; Kajikuri J; Hori E; Nagami C; Matsunaga T; Kimura K; Itoh T
Biol Pharm Bull; 2014; 37(6):996-1002. PubMed ID: 24705256
[TBL] [Abstract][Full Text] [Related]
20. Cerivastatin prevents tumor necrosis factor-alpha-induced downregulation of endothelial nitric oxide synthase: role of endothelial cytosolic proteins.
González-Fernández F; Jiménez A; López-Blaya A; Velasco S; Arriero MM; Celdrán A; Rico L; Farré J; Casado S; López-Farré A
Atherosclerosis; 2001 Mar; 155(1):61-70. PubMed ID: 11223427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
